The researchers then investigated the hypoglycaemic mechanism of these two substances and found that they could effectively improve insulin resistance and lower blood glucose through the IRS-1/PI3K/Glut-4 signalling pathway, and that the binding of the insulin receptor (IR) to its corresponding substrates could also affect the activation of one of these signalling mechanisms in type II diabetes. Here, SLC2A4 is linked to Insulin resistance.